




   Page 1 of 36 
 
Validation of Arxula Yeast Estrogen Screen assay for 
detection of estrogenic activity in water samples: Results 
of an international interlaboratory study  
 
Karina Hettwer a, Martin Jähne a, Kirstin Frost a, Martin Giersberg b, Gotthard Kunze b, 
Michael Trimborn c, Martin Reif c, Jochen Türk d, Linda Gehrmann d, Freddy Dardenne e, 
Femke De Croock e, Marion Abraham f, Anne Schoop f, Joanna J. Waniek f, Thomas Bucher 
g, Eszter Simon g, Etienne Vermeirssen g, Anett Werner h, Karin Hellauer i, Ursula Wallentits i, 
Jörg E. Drewes i, Detlef Dietzmann j, Edwin Routledge k, Nicola Beresford k, Tamara Zietek l, 
Margot Siebler l, Anne Simon m, Helena Bielak m, Henner Hollert n, Yvonne Müller n, Maike 
Harff n, Sabrina Schiwy n, Kirsten Simon o, Steffen Uhlig a,* 
 
a QuoData GmbH, Prellerstr. 14, 01309 Dresden, Germany 
b Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Corrensstr. 3, 06466 Seestadt OT 
Gatersleben, Germany 
c Erftverband, Am Erftverband 6, 50126 Bergheim, Germany 
d Institut für Energie- und Umwelttechnik e. V. (IUTA, Institute of Energy and Environmental Technology), 
Bliersheimer Str. 58-60, 47229 Duisburg, Germany 
e University of Antwerp, Systemic Physiological and Ecotoxicological Research (SPHERE), Groenenborgerlaan 
171/U7, 2020 Antwerp, Belgium 
f Leibniz Institute for Baltic Sea Research Warnemünde, Department Marine Chemistry, Seestraße 15, 18119 
Rostock, Germany 
g Swiss Centre for Applied Ecotoxicology Eawag-EPFL, Überlandstraße 133, 8600 Dübendorf, Switzerland 
h Technical University Dresden, Institute of Natural Science, Bioprocess Engineering, Helmholtzstraße 10, 01062 
Dresden, Germany 
i Technical University of Munich, Department of Civil, Geo and Environmental Engineering, Chair of Urban Water 
Systems Engineering, Am Coulombwall 3, 85748 Garching, Germany 
j SYNLAB Umweltinstitut GmbH, Hauptstraße 105, 04416 Markkleeberg, Germany 
k Brunel University London, Institute for Environment, Health and Societies, Halsbury Building, UB8 3PH 





   Page 2 of 36 
 
l Technical University of Munich, Department of Nutritional Physiology, Gregor-Mendel-Straße 2, 85354 Freising, 
Germany 
m IWW Rheinisch-Westfälisches Institut für Wasserforschung gemeinnützige GmbH, Moritzstr. 26, 45476 
Mülheim an der Ruhr, Germany 
n RWTH Aachen University, Institute for Environmental Research, Worringerweg 1, 52074 Aachen, Germany 
o New diagnostics GmbH, Pollinger Straße 11, 81377 München, Germany 
 
(*) Corresponding author: Steffen Uhlig, QuoData GmbH, Prellerstr. 14, 01309 Dresden, 
Germany, Email: uhlig@quodata.de, Phone: +49 351 40 28 867 0, Fax: +49 351 40 28 867 





   Page 3 of 36 
 
Abstract  
Endocrine-active substances can adversely impact the aquatic ecosystems. A special 
emphasis is laid, among others, on the effects of estrogens and estrogen mimicking 
compounds. Effect-based screening methods like in vitro bioassays are suitable tools to 
detect and quantify endocrine activities of known and unknown mixtures.  
This study describes the validation of the Arxula-Yeast Estrogen Screen (A-YES®) assay, an 
effect-based method for the detection of the estrogenic potential of water and waste water. 
This reporter gene assay, provided in ready to use format, is based on the activation of the 
human estrogen receptor alpha. The user-friendly A-YES® enables inexperienced operators 
to rapidly become competent with the assay.  
Fourteen laboratories from four countries with different training levels analyzed 17β-estradiol 
equivalent concentrations (EEQ) in spiked and unspiked waste water effluent and surface 
water samples, in waste water influent and spiked salt water samples and in a mixture of 
three bisphenols. The limit of detection (LOD) for untreated samples was 1.8 ng/L 17β-
estradiol (E2). Relative repeatability and reproducibility standard deviation for samples with 
EEQ above the LOD (mean EEQ values between 6.3 and 20.4 ng/L) ranged from 7.5 to 
21.4% and 16.6 to 28.0%, respectively. Precision results are comparable to other frequently 
used analytical methods for estrogens.  
The A-YES® has been demonstrated to be an accurate, precise and robust bioassay. The 
results have been included in the ISO draft standard.  
The assay was shown to be applicable for testing of typical waste water influent, effluent and 
saline water. Other studies have shown that the assay can be used with enriched samples, 
which lower the LOD to the pg/L range.  
The validation of the A-YES® and the development of a corresponding international standard 
constitute a step further towards harmonized and reliable bioassays for the effect-based 
analysis of estrogens and estrogen-like compounds in water samples.  
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1 Introduction 
Endocrine-disrupting compounds (EDC) pose a global threat to human health and the 
environment (Bergman et al., 2012). Concerns about the effects of natural estrogens and 
estrogen mimics to the environment stem from their widespread use in personal care 
products (Karpuzoglu et al., 2013), industrial chemicals (Rochester et al., 2015), livestock 
breeding and agriculture (Gall et al., 2011) and human pharmaceutical products (Maitre 
2013). Several examples include the use of estrogens in contraceptives, hormonal 
replacement therapy or for treating menopausal and post-menopausal symptoms. Depending 
on their use patterns, EDCs enter aquatic ecosystems from different human and animal 
sources (Adeel et al. 2017). The elimination of estrogenic micro-pollutants in conventional 
waste water treatment plants is incomplete so far and effluents are one of the major sources 
of estrogens and estrogenic transformation products into watercourses (Filby et al., 2007; 
Racz and Goel, 2010; Gehrmann et al., 2016). Because of the hormone-like action of 
estrogens and estrogen acting compounds and their ubiquity in environment, a number of 
efforts have been made to investigate their impacts on the ecosystems. To dates, there are 
numerous laboratory and field studies showing the adverse effects of natural estrogens and 
estrogenic EDCs in marine organisms that result in altered reproductive output in gastropods 
and altered sexual maturation in wild roach (Oehlmann et al., 2006; Benstead et al., 2011; 
Jobling et al., 2002; Jobling and Tyler, 2003; Lange A. et al., 2008).  
To address the problem of EDCs and micro-pollutants in general, the European Union Water 
Framework Directive (WFD) was adopted in 2000 (European Commission 2000). The WFD 
aims to improve overall surface water quality by (i) achieving a good ecological and chemical 
status for surface waters and (ii) a good chemical and quantitative status for ground waters in 
Europe. The Article 8 of the WFD calls for the necessity of monitoring programs to establish 
a coherent and comprehensive overview of the water status within each river basin. Typically 
targeted chemical analysis strategies are applied for monitoring the chemical status. These 
methods are focused on the type and concentration of chemicals in a sample, and can 
precisely identify single known substances within environmental samples. However, they 
require a priori knowledge about the substances to be monitored. For technical and 
economic reasons, it is not possible to analyze, detect and quantify all substances that are 
present in the aquatic environment (Wernersson et al., 2015). Chemical monitoring is, 
therefore, performed instead only on regulated and harmful substances.  
Unlike other analytical techniques, effect-based bioassays present a different approach to 
monitor water quality. Using bioassays offers a possible assessment of the cumulative effect 
of all compounds present in a sample (Silva et al., 2002). Thus, the effect of both known and 
unknown substances is captured (Leusch et al., 2014; Kunz et al., 2015).  
Bioassays can complement a chemical analysis in various ways. They can provide additional 
information, or can be used as screening tools that initiate a chemical analysis in case of 
positive results, or can be used if routine chemical methods do not reach the required 
detection limits. For example, the environmentally relevant concentrations for the estrogens 
17β-estradiol (E2) and 17α-ethinylestradiol (EE2) are in the low ng/L or pg/L range (Kunz et 
al., 2015). Here, routine analytical methods are often not sensitive enough, allowing 
bioassays to be used to quantify the estrogenic activity of a water sample in terms of a 17β-
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Realizing the problem of chemical mixtures in water quality monitoring, the CMEP (Chemical 
Monitoring and Emerging Pollutant) group, which acts in the context of Common 
Implementation Strategy (CIS) of the WFD, started activities on effect-based bioassays and 
published a technical report on aquatic effect-based monitoring tools (Wernersson et al., 
2015). Beyond this report, several other recommendations for integration of bioassays in 
water quality monitoring are also available (Brack et al., 2016; Brack et al., 2017; Altenburger 
et al., 2015; Hecker and Hollert, 2011; Hamers et al., 2013; Di Paolo et al., 2016, Tousova et 
al. 2017).  
A prerequisite for the implementation of effect-based tools in water quality monitoring is the 
availability of reliable and standardized test methods. On an international level, the ISO 
(International Organization for Standardization) is the relevant body for the development of 
standards. The scope of the ISO Technical Committee 147 is standardization in the field of 
water quality with emphasis on environmental issues. In this context, the standardization of 
assays for the determination of the estrogenic potential of water and waste water were 
included in the working program of ISO TC 147 in 2013, with Arxula Yeast Estrogen Screen 
(A-YES®) assay among them (ISO/DIS 19040-2) (ISO Standards Catalogue).  
The present study describes the validation of the A-YES® within the framework of an 
interlaboratory trial in the context of the standardization process. This study is the first 
international interlaboratory validation of the A-YES®. The interlaboratory trial was organized 
by the working group “Genotoxicity and endocrine effects” of the DIN Standardization 
Committee 119-01-03-05-09. The samples comprised river water, influent and effluent of a 
municipal waste water treatment plant, influent of a hospital treatment plant, saline water, a 
sample spiked with three bisphenols (Z, S, A) and a negative control. The results of the study 
have been included in the draft standard (ISO/DIS 19040-2) to demonstrate the applicability 
of the method and to provide validation data. The ISO standard will most likely be published 
in spring 2018.  
The validation of the A-YES® and the development of the corresponding international 
standard constitute a step further towards harmonized and reliable bioassays for the effect-
based analysis of estrogens and estrogen-like compounds in water samples.  
2 Material and methods 
2.1 Coordination and participants 
The study was organized by the working group “Genotoxicity and endocrine effects” of the 
DIN. Coordination of the interlaboratory trial for ISO/CD 19040-2 was done by QuoData 
GmbH with major support from the German Federal Institute of Hydrology (BfG). 
Fourteen laboratories from four countries were registered for the interlaboratory trial (eleven 
from Germany, one each from Switzerland, Belgium and the United Kingdom). Laboratories 
included private companies, universities and public authorities. The laboratories had different 
training statuses; more than half of them performed only a few A-YES® tests prior to the start 
of the study. These tests consisted of the analysis of water samples according to the same 
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2.2 Samples and pretesting 
Nine samples were analyzed: waste water, surface water, saline water, a mixture of 
bisphenols and a control sample (Table 1). A broad range of samples was chosen to cover 
the scope of the ISO/DIS 19040-2 method. As the yeast Arxula adeninivorans is highly salt 
tolerant (Gellissen 2005), a saline water sample was chosen to demonstrate the applicability 
of the assay for such water types. Additional information regarding the sampling sites, 
sample volumes, spiking and waste water treatment plants, is available in the supplementary 
information (SI).   
A pre-test was performed to ensure that all participating laboratories received a set of good 
quality samples. The samples were tested in serial dilutions according to the testing scheme 
of the interlaboratory trial. In all tests, the samples spiked with E2, EE2 and the bisphenols 
showed estrogenic activity in the quantifiable range of the assay, and samples expected to 
show no estrogenic effect behaved accordingly. 
Experiments analyzing the stability of samples of the same origin were performed in 
preparation of the interlaboratory trial. The effects of storage and shipping temperature and 
filtration were examined. Based on the results of the stability testing the samples were stored 
at ≤ -18°C before and after shipping. Shipping was done within 24 hours at no more than 2 
°C and the temperature was recorded during shipping. Amber glass bottles (40 ml capacity) 
with polytetrafluoroethylene (PTFE) lined caps were used as sample containers. 
Although filtration of influent samples leads to a better stability, it also causes a significant 
reduction in estrogenic activity. Therefore, coarse particles were removed by sedimentation 
at low centrifugation speeds (20 min at 3500 g at room temperature).  
In addition, several tests were performed prior to the interlaboratory study to verify the 
inhibition potential of different kinds of samples on the reporter enzyme phytase. No 
significant reduction of enzymatic activity was observed for samples with high matrix load (e. 
g. saline and waste water samples). 
Table 1: Samples analyzed with the Arxula Yeast Estrogen Screen assay in the interlaboratory t rial. 
Samples were provided by the BfG (#1, #2, #3, #5, #6 , #9), the Institute of Energy and Environmental 
Technology, IUTA (#4), the Leibniz Institute for Ba ltic Sea Research, IOW (#8) and QuoData GmbH (#7). 
Nr. Type Description Spiking 
1 
Waste water 
Effluent, municipal-WWTP, Koblenz -- 
2 Effluent, municipal-WWTP, Koblenz 10 ng/L EE2 
3 
Influent, municipal-WWTP, Koblenz, 
(centrifuged) -- 
4 
Influent, hospital-WWTP, Gelsenkirchen 
(settled) 
-- 
5 Surface (river) 
water 
Rhine -- 
6 Rhine 15 ng/L EE2 
7 
Aqueous mixture 
of bisphenols Mixture of BPA, BPS, BPZ 
242 µg/L BPA,  
48 µg/L BPS,  
39 µg/L BPZ  
8 Saline water Baltic Sea 1.4 ng/L E2 and 8 ng/L EE2 
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2.3 Materials for participants 
Each of the participants received three sets of samples. Each set contained one aliquot of 
the nine samples (coded). The participants were also informed about the storage 
requirement of the samples after arrival (≤ -18°C), as well as the testing procedure. Each 
participant was kindly requested to analyze at least two sample sets.  
All reagents and consumables for the A-YES® were provided by new diagnostics GmbH 
(München, Germany) and distributed to the participants by QuoData GmbH. The material 
included freeze-dried A. adeninivorans G1214/YRC103-hERα-phyK, E2 stock solution (1 
mg/L in ethanol), sterile yeast minimal medium (fivefold concentrated), sterile saline yeast 
minimal medium (fivefold concentrated, containing 140 g/L sodium chloride), substrate buffer 
(0.5 mol/L citric buffer), developer (3  mol/L NaOH), substrate tablets (5 mg p-nitrophenyl 
phosphate disodium salt hexahydrate, each), 0.1 mol/L HCl, 0.1 mol/L NaOH, deep well 
plates, microtiter plates and air permeable foil. All of the provided materials (yeast, reagents, 
media and buffer) for the interlaboratory trial belonged to the same batch. Participants were 
instructed to store the test material and reagents under cool conditions (2 – 8 °C).  
2.4 Testing of samples with Arxula Yeast Estrogen Screen assay 
The tests were performed according to the method described in ISO/DIS 19040-2, “Water 
quality – Determination of the estrogenic potential of water and waste water” Part 2: Yeast 
estrogen screen (A-YES, Arxula adeninivorans). 
The A-YES® is a reporter gene assay for the measurement of the activation of the human 
estrogen receptor alpha (hERα) in the presence of a sample containing compounds which 
cause estrogenic effects. The assay detects the estrogenic activity of the whole sample, 
including possible additive, synergistic and antagonistic mixture-effects.  
The human estrogen receptor alpha gene is constitutively expressed in the yeast cell under 
the control of a TEF1 promoter. Upon entering the yeast cells, agonists of the estrogen 
receptor will bind to the estrogen receptor protein, forming the receptor-ligand-dimers that 
subsequently induce the transcription of the reporter gene phyK, which encodes the enzyme 
phytase. The activity of phytase as an indicator for the estrogenic potential of the sample is 
determined by using an appropriate substrate which is cleaved into a final product of 
reaction. This product, having a distinct color, can be detected photometrically. Quantification 
is carried out through calibration with E2. 
The E2 stock solution (1 mg/L in ethanol) was diluted with ultrapure water according to 
ISO/DIS 19040-2 to obtain calibration levels with the following E2 concentrations: 80 ng/L, 
40 ng/L, 20 ng/L, 8 ng/L 4 ng/L, 2 ng/L, 1 ng/L.  
The conductivity and pH of the samples were measured in an aliquot of each sample with a 
pH/conductivity measuring device. Adjustment of the pH was done with 0.1 mol/L HCl or 0.1 
mol/L NaOH. To avoid contamination of the sample by the pH/conductivity device, the 
determined volume of a titrated base or acid solution was added to another aliquot of the 
sample.  
For the analysis of samples using the ISO/DIS 19040-2 method, the samples were diluted 
with ultrapure water or with ultrapure water adjusted with sodium chloride to the same 
conductivity as the sample. The analyzed dilution levels for each sample are summarized in 
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water ordinance (Waste Water Ordinance, 2004).  









Samples tested in 
this dilution Sample Dilution water 
Yeast 
suspension 
1.0 1.25 400 0 100 samples 1 to 9 
1.6 2.0 250 150 100 samples 1 to 9 
2.4 3.0 133.3 266.7 100 samples 1 to 6 and 9 
3.2 4.0 100 300 100 samples 1 to 9 
4.8 6.0 66.7 333.3 100 samples 1 to 6 and 9 
6.4 8.0 50 350 100 samples 1 to 9 
9.6 12.0 33.3 366.7 100 samples 1 to 6 and 9 
 
The samples were subsequently analyzed with the A-YES® according to the following 
procedure:  
Freeze dried yeast cells were washed three times with diluted minimal medium with 
alternating centrifugation (3000 g) and resuspension steps. The washed cells were 
reactivated 1 h at 30 °C on an incubation shaker with appropriate shaking frequency. The 
deep well plate was filled with the negative control (ultrapure water), blanks, the dilution 
series of the samples and the calibration levels of the standard (E2). Replicates were as 
follows: two replicates for the negative control and the reference standard; four replicates for 
each dilution level of the sample; two replicates for the sample blank (undiluted sample); two 
replicates for the blank of the negative control and two replicates for the blank of the E2 
concentration 80 ng/L. Based on the conductivity of the samples, fivefold minimal medium for 
inoculation was prepared using fivefold minimal medium with and without sodium chloride to 
obtain a similar salinity in all 96 wells per plate. To assess sample associated microbial 
growth and sample coloration blanks were inoculated with 100 µl of prepared fivefold minimal 
medium without yeast. The reactivated yeast was diluted with the prepared fivefold minimal 
medium and all wells except the blanks were inoculated with yeast medium suspension with 
the same cell density per well. The deep well plate was sealed with an air permeable foil and 
incubated 24 ± 2 h in an incubation shaker at 31 ± 1 °C with an appropriate shaker frequency 
depending on the laboratory. After an overnight cultivation, the yeast cells were separated 
from the culture by centrifugation (10 min, 700 g) and 50 µL of the clear supernatant of each 
well was transferred into a clear microtiter plate. Substrate solution for the reporter enzyme 
phytase was prepared by adding 5 mg p-nitrophenyl phosphate disodium salt hexahydrate 
tablets (Sigma-Aldrich) to 0.5 mol/L citric buffer to reach a concentration of 1 mg/mL. A 50-µL 
substrate solution was then added into each well of the microtiter plate filled with supernatant 
followed by a brief centrifugation step (10 s, 100 g). The plate was incubated at 37 °C for one 
hour and the absorption was determined at 405 nm in a microplate reader afterwards. Next, 
100 µL of developing solution (3 mol/L NaOH) were pipetted to every well and the absorption 
of the colored product was determined at 405 nm again. The deep well plate with the 
remaining cell pellet was shaken rigorously to resuspend the yeast cells, and an aliquot of 
the yeast cell suspension of every well was transferred and diluted into a second microtiter 
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the optical density at 630 nm (alternatively at 600 or 620 nm).  
2.5 Evaluation of raw data 
Dose-response curve and sample EEQ 
For each test performed (each plate), the raw data were analyzed as described in ISO/DIS 
19040-2: raw data were analyzed for outliers, growth effects and sample coloration effects, 
and the corrected absorbance and induction rates were calculated.  
Subsequently, the dose-response relationship for the E2 reference compound was calculated 
with a four-parameter logistic model (Hill 1910) (see also supplementary information).  
The dilution-specific EEQ and the EEQ of the undiluted sample were calculated. To obtain 
the EEQ for the undiluted sample, the EC20 approach was followed, namely, the 20% effect 
level of the sample was interpolated from the 20% effect level of the E2 reference. The EEQ 
concentration for the undiluted sample was derived by dividing the E2 concentration needed 
to obtain 20% effect by the dilution level of the sample needed to obtain the 20% effect.  
The caveat for this approach is that the relative growth of the tested sample dilutions has to 
be greater than 0.85 (compared to negative control and the E2 reference), thus this 
conservative method may restrict the number of usable results. Nevertheless, it ensures that 
the estrogenic effect of a sample is not significantly overestimated due to the growth 
correction.  
Apparent recovery 
The recovery was calculated for the samples 2, 6, 7 and 8, considering the relative potency 
of the A-YES® for the spiked compounds EE2, BPA, BPS and BPZ.  
The relative potency is used to express the biological activity of a compound in comparison 
to the natural hERα ligand and calibration standard E2. It is defined by a ratio between the 
EC50 of E2 and the EC50 of the respective compound. The relative potencies of E2, EE2, 
BPA, BPS and BPZ are 1, 1.2, 1.68 * 10-5, 0 and 1.23 * 10-4, respectively. The expected EEQ 
of the samples 2, 6, 7 and 8 was calculated by multiplying the spiked concentration with the 
relative potency and summation of the result for all spiked compounds (see also 
supplementary information). 
The recovery of a sample is defined as a ratio of the overall empirical mean and the 
expected mean. Subsequently the term apparent recovery is used to distinguish the recovery 
associated with an extraction procedure from the recovery without extraction (Burns et al., 
2002).  
Limit of detection (LOD), critical concentration (CC) and limit of quantification (LOQ) 
The limit of detection (LOD), the critical concentration (CC) and the limit of quantification 
(LOQ) are performance parameters that were also determined. LOD and CC reflect the 
concentration at which a sample or a sample dilution is shown to mediate estrogenic activity. 
The limits take different sources of variation into account. Calculation of LOD is based on the 
plate-specific variability of the negative control and the E2 calibration levels, thus the 
uncertainty of the underlying four-parameter model is considered. The critical concentration 
is the concentration at the induction rate 1.18, which corresponds to 1.18 times the bottom 
curve point of the four-parameter dose response curve. This limit was determined based on 
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the A-YES®. The LOQ is the concentration at which the calculated EEQ has an uncertainty of 
not more than 33.3%. The calculation is based on the concentration’s 95 %-prediction 
interval, which is determined using the bootstrap method (Efron 1979). The calculated LOD, 
CC and LOQ refer to the concentration in the sample.  
Validity 
Prior to the evaluation of method performance, the validity of each test (each plate) was 
checked according to following criteria (as stated in Clause 10 of ISO/DIS 19040-2).  
The following criteria relating to the negative control, the reference standard and certain 
characteristics of the dose-response curve were checked for: 1) EC50 (half maximal effective 
concentration) between 7 and 35 ng/L E2, 2) Critical concentration equal or below 8 ng/L E2, 
3) Ratio between upper and lower level of dose-response relation ≥ 4 and ≤ 20, 4) 
Calibration range coverage ≥ 75%, 5) Variabilities of residuals ≤ 12% and 6) Final mean cell 
density after overnight incubation ≥ 1. If any of the above mentioned criteria were not met, 
the entire test was considered invalid.  
In addition, the relative growth and variability of corrected absorbance at 405 nm for each 
dilution level were checked as sample-specific criteria with thresholds ranging from ≥ 0.3 to ≤ 
3.5 and ≤ 15%, respectively. If one of the sample specific criteria was not met (even after 
outlier elimination), the respective dilution level was excluded from further statistical 
evaluation.  
All calculations described in this section were performed using the software GAUSS (Aptech 
Systems, Chandler (AZ), USA), a matrix programming language for mathematics and 
statistics.  
2.6 Evaluation of method performance 
Statistical method validation was carried out according to ISO 5725-2 (ISO 5725-2 2002) 
using the software PROLab (QuoData GmbH, Dresden, Germany). Repeatability (sr) and 
Reproducibility (sR) standard deviations were calculated for the EEQ for each of the analyzed 
dilution levels and for the undiluted sample. The formulas for calculation of sr and sR are 
given as supplementary information.  
Beyond the precision analysis for the sample EEQs, the following validation criteria were 
taken into consideration: sensitivity in terms of limit of detection (LOD), critical concentration 
(CC), limit of quantification (LOQ), EC50 (half maximal effective concentration) and apparent 
recovery.  
The scheme of validation procedure of sample analysis with the A-YES®, the subsequent 
evaluation of the raw data and the final evaluation of method performance are shown in 
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3 Results 
3.1 Useable results 
Six of the 14 participating laboratories had a previous experience with the A-YES®. The 
remaining eight laboratories successfully established the A-YES® test within a few weeks 
before start of the interlaboratory trial.  
One laboratory failed to follow the test procedure and results were completely excluded from 
further analysis. There were problems in determining the yeast cell density after incubation 
because the yeast pellet was not sufficiently resuspended. As a result, the cell density varied 
considerably, making the evaluation and correction of growth effects not possible.  
For the 13 remaining laboratories, 45 out of 256 results were excluded from the statistical 
analysis according to ISO 5725-2. More detailed information relating to usable results is 
summarized in Table 3. For each sample, the number of excluded results and corresponding 
reasons are provided. Results were excluded because either the E2 dose-response curve 
was not reliable, or pipetting errors occurred, or the relative growth of a sample was too low.  
Relating to the E2 dose-response curves, there were various causes that led to the exclusion 
of the results. On the one hand the variability of results was too high (residual standard 
deviation (RSD) > 12%), or the curve did not reach the upper plateau on the other hand 
(calibration range coverage (CRC) < 75%), or both were the case. An incomplete dose-
response curve does not appear to be a reason to exclude the results completely. However, 
it does not allow a reliable estimation of the EC50, which must be within a certain acceptable 
range. Causes for a variability of single results being too large and an incomplete dose-
response curve may result from the following possibilities: carryover of yeast when 
transferring the clear supernatant from the deep well plate to a microliter plate; pipetting 
errors during preparation of the E2 dilution series, also by using different pipettes; air bubbles 
in the supernatant; inappropriate shaker frequencies and unsuitable temperature during the 
incubation phase. The complete 96-well plate was excluded, regardless of the results from 
the samples.  
In line with the pipetting errors, it has occasionally occurred that yeast was mistakenly added 
into microtiter wells not designated for yeast. These so-called blank wells are required to 
evaluate and correct the inherent coloration of the sample and artificial cleavage of the 
enzyme substrate. Within the interlaboratory trial, samples with missing blanks were 
excluded from further analysis in order to ensure a uniform evaluation procedure. In the 
worst scenario, ignoring the blanks leads to an overestimation of the estrogenic activity of a 
sample. 
In a few cases, the relative growth of the analyzed sample dilutions was below the threshold 
value of 85%. Those samples were excluded from further analysis because the inhibition of 
yeast cell growth by the sample was too strong (cytotoxic effects).  
The total proportion of results excluded due to an unreliable E2 dose-response curve, 
pipetting errors and sample-related insufficient relative growth were 11.3%, 3.1% and 3.1% 
(in the total of 17.6%), respectively. When the training level of the participants was taken into 
account, the results for experienced laboratories were 5.1%, 2.7% and 1.6% (in the total of 
9.4%), and for unexperienced laboratories 6.3%, 0.4% and 1.6% (in the total of 8.2%). There 
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frequent pipetting errors, specifically by missing sample blanks. However, the difference is 
insignificant.  
The largest number of invalid results was obtained for the unspiked effluent (#1) and the 
hospital-influent sample (#4) with 21.4% and 31.0%, respectively. In both cases, more than 
half of invalid results were due to non-reliable E2 dose-response curves. For the hospital-
influent sample, one third of the invalid results were caused by insufficient growth of the 
yeast cells in the analyzed sample dilutions.  
After elimination of invalid results, the method performance according to ISO 5725-2 was 
evaluated based on 82.4% of all results (211 out of 256 single results). Within this evaluation, 
outlier tests for single measurements and for laboratory mean values were performed. As a 
result, all values of laboratory 05 for sample #7 were excluded because the intra-laboratory 
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Table 3: Overview of number and validity of measure ments for the analyzed samples. meas. = measurement s; LOD = limit of detection.  
 Sample 
1 2 3 4 5 6 7 8 9 
Laboratories 13 13 13 13 13 13 13 13 13 
Measurements 28 28 28 29 29 28 29 29 28 
Laboratories with valid results 13 13 12 12 13 12 12 12 13 
Valid measurements 22 25 25 20 25 23 24 24 23 
Invalid meas. 
related to dose-response curve RSD > 12 % and / or CRC < 75 % 4 2 2 5 3 2 4 4 3 
pipetting error sample blank missing 1 1 1 1 1 1 0 1 1 
related to sample relative growth < 0.85   1 0 0 3 0 2 1 0 1 
total 6 3 3 9 4 5 5 5 5 
Invalid meas. 
(%) 
related to dose-response curve RSD > 12 % and / or CRC < 75 % 14.3 7.1 7.1 17.2 10.3 7.1 13.8 13.8 10.7 
pipetting error sample blank missing 3.6 3.6 3.6 3.4 3.4 3.6 0.0 3.4 3.6 
related to sample relative growth < 0.85   3.6 0.0 0.0 10.3 0.0 7.1 3.4 0.0 3.6 
total 21.4 10.7 10.7 31.0 13.8 17.9 17.2 17.2 17.9 
Outliers excluded - single meas. acc. to ISO 5725-2 0 0 0 0 0 0 0 0 0 
Outliers excluded - laboratory means acc. to ISO 5725-2 0 0 0 0 0 0 1 0 0 
Laboratories with valid results after outlier elimination 13 13 12 12 13 12 11 12 13 
Valid measurements after outlier elimination 22 25 25 20 25 23 22 24 23 
Measurements <LOD 17 1 0 0 22 0 1 0 23 
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3.2 Sensitivity 
Dose-response curves for the reference standard E2 were obtained for each assay plate 
from each participating laboratory, in total for 99 plates. To characterize the sensitivity of the 
test method, the LOD, the CC, the LOQ and the EC50 were calculated.  
The LOD was calculated for each plate considering the plate specific variability of measured 
values for the negative control and the reference standard. The average LOD was 1.8 ng/L 
E2 and ranged from 0.7 to 3.7 ng/L E2. The CC ranged from 1.5 to 3.6 ng/L E2 with an 
average of 2.4 ng/L E2. Both LOD and CC are a concentration above which a sample or a 
sample dilution is assessed to mediate estrogenic activity. But for the calculation of the limits, 
different sources of variation are considered (see section 2.5). The LOQ ranged from 1.1 to 
6.3 ng/L E2 with an average of 2.5 ng/L E2. The EC50 values ranged from 8.0 to 16.5 ng/L E2 
with an average of 12.2 ng/L E2.  
All concentrations refer to the concentration in the sample. An LOD of 1.8 ng/L E2 means 
that 1.8 ng/L EEQ can be detected in a sample. 
3.3 Repeatability and reproducibility for EEQs of t he undiluted sample 
The precision of the A-YES® relating to the EEQ of the undiluted sample was determined by 
means of the repeatability and reproducibility standard deviation (sr and sR, respectively). 
The results for samples with quantifiable EEQ are summarized in Table 4, together with the 
mean EEQ and the ratio between sR and sr. A graphical presentation of the results for 
samples with measurable EEQs is shown in Figure 2.  
Results for samples showing no estrogenic effect are presented in Figure 3. For each sample 
the test and laboratory specific LOD is shown as upper line of the triangle. Those results are 
also shown to demonstrate that a negative result depends on the test specific LOD, and a 
negative results not always entails the estrogenic effect of 0, but rather a value between 0 
and the LOD.  
Waste water samples 
The unspiked effluent sample (#1) was below the LOD for the majority of participants (77%). 
The mean EEQ (across laboratories) was 8.8 ng/L for the spiked effluent (#2), 13.9 ng/L for 
the municipal influent (#3) and 20.4 ng/L for the hospital influent (#4).  
Repeatability standard deviations (sr) for the municipal WWTP samples (#2, #3) were 12.9 
and 17.0%, respectively. The reproducibility standard deviation (sR) was 28% for both 
samples. These are the highest values compared to all other samples. Nevertheless, these 
precision parameters reflect a good performance.  
The repeatability and reproducibility standard deviation were 8.6 and 16.7%, respectively, for 
the hospital-influent sample (#4). It is worth mentioning that the precision parameters almost 
adopt the lowest values for this sample. Only the mixture of bisphenols (#7) showed slightly 
better results.  
These good results from the waste water effluent and influent emphasize the applicability of 
the A-YES® for such challenging water samples.  
The ratio sR/sr is an additional characteristic of method performance. Usually this ratio adopts 
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error. If it is larger than 2, reproducibility mainly depends on the systematic lab bias. 
For the waste water samples, the ratios were 2.2 (#2), 1.6 (#3) and 1.9 (#4), reflecting a 
good balance between random repeatability error and systematic lab bias.  
Surface water samples 
The unspiked Rhine sample (#5) was below the LOD for almost all participants (88 %). The 
mean EEQ of the spiked Rhine sample (#6) was 17.4 ng/L. The repeatability and 
reproducibility standard deviation were 21.4 and 24.9%, respectively. Here, the ratio between 
sR and sr is 1.2, indicating that the reproducibility standard deviation was dominated by the 
random repeatability error.  
Mixture of bisphenols 
For the mixture of BPA, BPS and BPZ (#7), the mean EEQ was 6.3 ng/L with a repeatability 
standard deviation of 7.5% and reproducibility standard deviation of 16.6%. The precision of 
this sample was best compared to all other samples, possibly due to a very low complexity 
(no interfering substances causing strong matrix effects). The sR/sr value of 2.2 indicates that 
laboratory bias is slightly higher than a random error.  
Saline water sample 
The mean EEQ of the spiked Baltic Sea sample (#8) was 9.0 ng/L. The repeatability and 
reproducibility standard deviation were 19.6 and 24.8%, respectively. The ratio sR/sr was 1.3. 
Here again, the reproducibility standard deviation was dominated by the random error. Thus, 
the results are comparable to the spiked Rhine sample.  
Control sample (field blank) 
The field blank functioned as a control for sampling, sampling material, and transportation 
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Table 4: Mean EEQ with 95% confidence interval (CI), relative reproducibility (s R) and repeatability 
standard deviation (s r) as well as their ratio (s R/sr) for the samples with EEQ above the LOD.  
Nr. Sample Mean (ng/L EEQ) with 95% CI sr % sR % sR/sr 
2 
Effluent, municipal-WWTP 
+10 ng/L EE2 8.8 (7.5 – 10.1) 12.9 28.0 2.2 
3 Influent, municipal-WWTP 13.9 (11.9 – 15.9) 17.0 28.0 1.6 
4 Influent, hospital-WWTP 20.4 (18.6 – 22.2) 8.6 16.7 1.9 
6 Rhine + 15 ng/L EE2 17.4 (15.4 – 19.4) 21.4 24.9 1.2 
7 BPA, BPS, BPZ 6.3 (5.7 – 6.9) 7.5 16.6 2.2 
8 
Baltic Sea + 1.4 ng/L E2 and 
8 ng/L EE2 
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Fig. 2: Summary of results for sample #2, #3, #4, #6 , #7 and #8. For each sample, the individual result s of 
the laboratories (diamonds), the within-lab mean an d variability (boxes), the overall mean (solid line ) with 
95% confidence interval (grey band) and the 95% pre diction interval (outer lines) are shown. Results o f 
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Fig. 3: Summary of results for sample #1, #5 and #9.  For each sample the test and laboratory specific 
LOD’s are shown as grey triangles (upper line) and results above the LOD are shown as diamonds. The 
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3.4 Repeatability and reproducibility for dilution level specific EEQs 
Furthermore, the repeatability and reproducibility standard deviation for the dilution level 
specific EEQs were determined. Table 5 summarizes these results in combination with the 
results from the undiluted sample.  
For dilution levels with results mostly above the LOD, the relative repeatability and 
reproducibility standard deviation are broadly comparable to the precision parameters of the 
undiluted sample. For dilution levels where the majority of results were below the LOD the 
precision parameters are clearly larger as expected.  
It is worth mentioning that for the two influent samples repeatability and reproducibility 
standard deviation for dilutions with EEQ around just above 2 ng/L is very good. This 
underpins the applicability of the A-YES® for highly complex water samples. 
A graphical representation of the relative repeatability and reproducibility standard deviation 
for all samples and analyzed dilution levels is shown in Figure 4. Both relative standard 
deviations are almost exclusively below 30% in the working range of the assay, with the 
lower limit at approximately 2 ng/L EEQ.  
 
Fig. 4: Relative repeatability and reproducibility standard deviation for the dilution specific EEQs for  all 
analyzed samples.  
 
Another aspect to be considered is the relation between sample dilution and EEQ. Figure 5 
shows the EEQ that was derived by multiplying the mean EEQ with the dilution level. 
Furthermore, the 95% confidence interval is indicated by the error bars. Interestingly, a 
systematic trend of the mean EEQs is observed from the influent samples, but not from other 
samples.  
This is not surprising because the effluent sample, the Rhine sample, the bisphenol-mixture 
and the Baltic Sea sample were spiked to an extent where EE2 and E2 (or three bisphenols) 
are dominating the mixtures, such that the dilution level and EEQ are inversely proportional. 
In contrast, the municipal and the hospital influent samples are naturally contaminated.  
In general, this nonlinear relation is frequently observed for bioassays (Vermeissen et al., 
2006). However, it leads to the question of how samples with non-linear relation between 
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In this study, the significance of dilution effects was determined by fitting a linear regression 
and checking the significance of the slope. If there is a significant dilution effect, then the 
slope is different from 0. If a linear regression is not appropriate, a polynomic 2nd order 
function may be used instead.  
A significant dilution effect was observed only from the two influent samples. This effect was 
also present in the laboratory-specific results. The extent of the effect was different between 
the two influent samples, suggesting that it is more pronounced for the municipal-WWTP 
influent.  
Because the extent of the dilution effect can vary from sample to sample, it is particularly 
important that this effect is analyzed and documented, and that the EEQs are calculated 
according to a standardized procedure. Further recommendations for the A-YES® are 












Fig. 5: Relation between sample dilution and EEQ of t he undiluted sample. Error bars indicate the 95% 
confidence interval. EEQ was independent of dilution in samples spiked with estrogens and the mixture 
of bisphenols (#2, #6, #7, #8); EEQ increased with in creasing dilution in two unspiked influent samples 
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Table 5: Mean EEQ, reproducibility (s R) and repeatability standard deviation (s r) for the dilution specific EEQs and the undiluted sample EEQ. Meas. = measurements; 
LOD = limit of detection. 
 Dilution Undiluted 
Sample Sample 1 1.6 2.4 3.2 4.8 6.4 9.6 
Effluent, municipal-WWTP + 
10 ng/L EE2 
Mean (ng/L EEQ) 8.1 5.6 4.2 3.2 2.2 1.9 1.0 8.8 
Meas. < LOD % 0.0 0.0 0.0 0.0 24.0 52.0 92.0 4.0 
sr % 13.1 12.2 18.6 20.4 18.2 28.6 62.4 12.9 
sR % 27.3 22.3 22.8 29.2 27.1 34.6 75.0 28.0 
Influent, municipal-WWTP 
Mean (ng/L EEQ) 9.4 7.5 6.2 5.3 4.3 3.6 3.0 13.9 
Meas. < LOD % 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 
sr % 13.5 17.0 15.2 14.5 15.4 15.4 18.1 17.0 
sR % 22.4 19.0 18.4 17.8 18.3 18.0 19.7 28.0 
Influent, hospital-WWTP 
Mean (ng/L EEQ) 16.8 11.3 8.3 6.3 4.7 3.8 2.8 20.4 
Meas. < LOD % 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 
sr % 22.6 25.5 18.9 12.1 14.3 17.4 35.3 8.6 
sR % 34.5 25.5 20.4 14.2 15.4 17.4 35.3 16.7 
Rhine + 15 ng/L EE2 
Mean (ng/L EEQ) 15.7 10.1 7.0 5.4 3.6 2.8 1.7 17.4 
Meas. < LOD % 0.0 0.0 0.0 0.0 0.0 4.0 56.0 0.0 
sr % 12.5 16.2 16.7 18.9 21.1 22.4 25.7 21.4 
sR % 22.5 20.8 22.0 25.5 26.7 30.3 41.1 24.9 
BPA, BPS, BPZ 
Mean (ng/L EEQ) 6.3 3.7  1.5  0.8  6.3 
Meas. < LOD % 0.0 4.0  50.0  89.3  4.2 
sr % 13.5 15.5  38.7  86.2  7.5 
sR % 19.1 21.9  48.6  91.2  16.6 
Baltic Sea + 1.4 ng/L E2 and 
8 ng/L EE2 
Mean (ng/L EEQ) 8.2 5.4  2.9  1.1  9.0 
Meas. < LOD % 0.0 0.0  12.0  73.1  0.0 
sr % 15.9 18.5  28.3  80.7  19.6 
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3.5 Analysis of spiked samples  
It should be noted that the recovery in terms of chemical analysis cannot be directly 
compared to effect-based bioassay results because such tests measure the cumulative 
effect of a sample including additive, synergistic, and antagonistic effects. These effects are 
directly influencing the recovery, especially in real samples with high matrix load. In light of 
this, the recovery for effect-based bioassays should not be interpreted as a validation 
parameter but as a feature of the sample. It is also worth mentioning that the recovery in 
chemical analysis usually refers to an extraction procedure. No such extraction procedure 
was used for the A-YES®. Therefore, the concept of apparent recovery is used herein (Burns 
et al., 2002).  
For spiked samples #2, #6, #7 and #8 an (apparent) recovery analysis was performed (Table 
6), considering the relative potency of the A-YES® for the specific compounds added to the 
samples. The relative potency is used to express the biological activity of a compound in 
comparison to the natural hERα ligand and calibration standard E2.  
The apparent recovery for the spiked samples varied between 70.8 and 96.7%, with the 
highest values belonging to the Rhine and Baltic Sea samples. The lower recovery of the 
effluent sample is most likely due to the high matrix load of the sample. However, the lowest 
recovery was observed from the mixture of three bisphenols; although, there are no 
interfering matrix components present. One reason perhaps is that the expected EEQ was 
derived from the sum of effects of single compounds, and that the actual mixture effect of the 
three bisphenols may be lower (or higher) than the sum of the single effects.  
Table 6: Apparent recovery for spiked samples based  on the mean and expected EEQ. 







+10 ng/L EE2   8.8 12.0 73.3 
6 Rhine + 15 ng/L EE2 17.4 18.0 96.7 
7 BPA, BPS, BPZ   6.3   8.9 70.8 
8 
Baltic Sea + 1.4 ng/L E2 and 
8 ng/L EE2   9.0 11.0 81.8 
4 Discussion 
The prerequisites of measurement methods used in monitoring and regulatory purposes, e.g. 
in the framework of water quality, or for examination of waste water, are sensitivity, 
specificity, reproducibility, ease of use and cost effectiveness – regardless of a targeted 
chemical or an effect-based method. For the performance assessment of A-YES®, the 
comparisons with typically used targeted chemical methods, as well as other effect-based in 
vitro assays, are set out hereinafter. Emphasis is laid on repeatability, reproducibility, 
sensitivity and applicability. Furthermore, we address some aspects concerning the 
calculation of a sample EEQ.  
Targeted chemical and effect-based methods have different approaches in measuring the 
estrogenic burden of a sample. Thus, a direct comparison between methods is not adequate, 
and the parameters’ specificity and recovery are not discussed in details. Typically, the 
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the cumulative effect of all estrogenic compounds present in a sample. This cumulative effect 
is more useful in answering questions relating to the effect of mixtures to a living organism. 
The necessity of the knowledge of individual contributions is often secondary, especially as 
the effect of substance mixtures may not be equal to the sum of the single effects. 
Repeatability and reproducibility 
In this interlaboratory study, the relative repeatability standard deviation for the A-YES® 
ranged from 7.5 to 21.4%, and the relative reproducibility standard deviation from 16.6 to 
28.0% (EEQ for undiluted sample).  
For targeted chemical analysis of steroid estrogens in aqueous samples using GC-MS or LC-
MS, the reported relative reproducibility standard deviation varies from single digits to more 
than 50%, depending on the analyte, matrix and measured concentration (Vanderford et al., 
2014). In particular, Vanderford et al. (2014) reported relative interlaboratory standard 
deviations between 20 and 30% for E2 and EE2 (after outlier elimination) in drinking and 
surface water. In a study led by Heath et al. (2010), estrogens were determined in tap water, 
river water and waste water influent and effluent after a solid-phase extraction. As the study 
reports results of a proficiency testing, each laboratory performed its own method. Either LC-
MS/MS or GC-MS was used for the analyses. The relative reproducibility standard deviations 
for GC-MS methods ranged from 20 - 45%, and the relative repeatability standard deviations 
varied between 9 and 22%. When the different sample types were taken into account, the 
relative repeatability standard deviation ranged from 9 – 11% (tap water), 13 – 16% (surface 
water), 10 – 17% (influent) and 13 – 22% (effluent). Likewise, the relative reproducibility 
standard deviation ranged from 30 – 40% (tap water), 25 – 45% (surface water), 20 – 22% 
(influent) and 21 – 33% (effluent). While the LC-MS methods performed similarly for E2, the 
results for EE2 were unfavorably high, up to approximately 200%.  
Other studies focusing on the within laboratory validation of LC-MS/MS methods for steroid 
estrogens report an intra- and inter-day variability for E2 and EE2 between 3 and 9% and 
between 3 and 11%, respectively (Fayad et al. 2013; Guo et al. 2013). Wozniak et al. (2014) 
conducted an in-house validation of a GC-MS method and received a relative within 
laboratory reproducibility ranging from 16.4 to 41.4% for E2 and EE2, respectively. Typically, 
these studies use standard solutions as samples, partly in combination with enrichment and 
extraction methods. One exception comes from the study by Fayad et al. (2013), which 
utilizes analyte-free effluent waste water samples in addition to standard solutions.  
Comparing the results of a targeted chemical analysis to the A-YES®, we found that the 
relative interlaboratory reproducibility standard deviation and the relative repeatability 
standard deviation using the standardized A-YES® is within the ranges reported for 
conventional targeted chemical analyses for estrogens. This also applies particularly to 
different water types, as shown by the comparison of Heath et al. (2010) and Vanderford et 
al. (2014). These publications, however, include enrichment and extraction step, therefore 
this source of variability is considered as well. If only standard solutions are examined, the 
repeatability within one laboratory is partial, but not always smaller (see Guo et al. (2013) 
and Wozniak et al. (2014)). However, this depends also on the calculation method used.  
Besides, the relative reproducibility standard deviation of the A-YES® is in general 
comparable to the conventional analytical chemistry (These et al., 2011), where a maximum 
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criterion. Interestingly, the A-YES® also fulfills this requirement for challenging matrices, such 
as the marine water and the waste water samples, including the hospital influent.   
Comparison of the relative repeatability and reproducibility standard deviation to other in vitro 
bioassays is confound by the fact that the statistical evaluation is not standardized, i.e. 
according to ISO 5725-2 (ISO 5725-2 2002). Following ISO 5725-2, the reproducibility 
standard deviation (sR) comprises the within and between laboratory (sr + sL) variability. 
Given the published data in the literature, it often remains unclear, whether the reproducibility 
standard deviation (sR) or one of its components is reported. However, it has been shown 
that the relative reproducibility standard deviation was between 33.6 and 72.7% for three 
yeast assays based on different modified Saccharomyces cerevisiae strains for the detection 
of estrogenic activity (Brix et al., 2010). These results are also comparable to the relative 
reproducibility standard deviation found in other interlaboratory studies, including yeast-
based assays (Dhooge et al., 2006; Andersen et al., 1999). For mammalian cell-derived 
estrogen receptor (ER) assays, relative reproducibility standard deviations between 30 and 
54% (Mehinto et al., 2015) and between 10 and 35% (Van Der Linden et al., 2008), 
respectively, were reported. It can be stated, that the relative reproducibility standard 
deviation for the A-YES® is comparable to and even better than these reported values.  
Generally, bioassays possess a relatively large inherent variation (Brix et al., 2010). As such, 
yeast-based assays can suffer from strain variations that underlie the differences in receptor 
levels (Zacharewski, 1997), resulting in relatively imprecise data (Auchus, 2014). In addition, 
a lack of harmonization of method protocols between different laboratories using the same 
bioassays, along with different training levels of operators, has led to a variation in test 
results. The A-YES® circumvents problems caused by strain variations and variable receptor 
levels by using a recombinant A. adeninivorans strain with chromosomally located 
heterologous genes (hERα, phyK) (Kaiser et al., 2010). Stable mitotic A. adeninivorans 
transformants were produced after passaging on selective and non-selective media 
(Klabunde et al., 2003). Furthermore, the production of large batches of A-YES® cells under 
standardized and controlled conditions in a bioreactor, subsequent lyophilization of the cells 
and a continuous control of the biosensor quality, help moderate biological variations. 
Sensitivity 
The European Directive 2013/39/EU has included the pharmaceuticals E2, EE2 and E1 
(estrone) on the watch list. Substances on this list are monitored EU-wide for the purpose of 
supporting future prioritization exercises in the framework of the WFD. This directive does 
not define environmental quality standards (EQS) for E2 and EE2. However, a former 
proposal for amending the priority substance list (European Commission 2011) suggested 
EQS for E2 and EE2. The proposed EQS for E2 of inland surface water is 0.4 ng/L, and 0.08 
ng/L for other (salt) surface waters. The proposed EQS for EE2 are 0.035 and 0.007 ng/L, 
respectively. These are the concentrations that should not be exceeded in order to protect 
aquatic environment and human health.  
Such low EQS values pose a major challenge for the detection using targeted chemical 
analysis, especially since the LOQs of the analytical methods must be at 30% of the EQS 
(EC 2009). In a recent report from Loos et al. (2015), analytical methods for possible WFD 
watch list substances such as E2 and EE2 were identified. The lowest LODs as reported by 
Williams et al. (2012) and Li et al. (2013) were 0.03 ng/L for E2 and 0.05 ng/L for EE2. The 
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those methods, the proposed EQS for E2 of inland surface water can be monitored. 
Monitoring of proposed EQS for EE2 is arguably difficult, and in fact it is not achievable for 
other (salt) surface waters. 
To accomplish LODs and LOQs in the lower pg/L range, a further development of enrichment 
and extraction steps is necessary. Current analytical methods apply enrichment factors that 
are typically around 1000, starting with a sample volume of approximately 1 L (EPA Method 
539, 2010; Isobe et al., 2003). However, it must be mentioned that enrichment and extraction 
procedures typically increase the bias, and thus alter the method accuracy (Isobe et al., 
2003) (Tomšíková et al., 2012).  
Within this study, only native samples were analyzed, and no enrichment or extraction steps 
were applied. There are two explanations for this. On the one hand, ISO/DIS 19040-2 
describes the testing of aqueous samples, regardless of any applied enrichment or extraction 
step. On the other hand, the variety of enrichment and extraction methods makes it 
impossible to validate each in combination with the A-YES®.  
However, even though not demonstrated in this interlaboratory study, such enrichment and 
extraction steps have been used in combination with the A-YES®, as shown by Gehrmann et 
al. (2016). With an LOQ of 2.5 ng/L EEQ and the fact that LOQs should be at 30% of the 
EQS (European Commission 2009) and the A-YES® that is slightly more sensitive for EE2 
than for E2 (factor of 1.2), an enrichment factor of approximately about 200 would be 
sufficient for detection of E2 and EE2 in inland and E2 in other (salt) surface waters. An 
enrichment factor of about 1000 would be effective for EE2 in (salt) surface waters. This by 
means holds under the assumption that enrichment and extraction steps do not alter method 
accuracy.  
Applications: sample types  
Within the framework of this interlaboratory study, it could be shown that different types of 
native water samples, including samples with high matrix load (municipal waste water 
effluent and influent, hospital waste water influent) as well as water with higher salinity 
(brackish and marine water), could be analyzed with the A-YES®. The robustness in terms of 
testable sample types is reflected by the fact that cytotoxic effects, which result in low yeast 
growth, occurred sporadically. It should be noted that with A-YES®, neither antibiotics are 
added to the yeast medium to suppress the background microflora, nor does it require sterile 
working during the test procedure. Owing to the robustness of the Arxula yeast against 
osmotic stress (Gellissen, 2005), the A-YES® is particularly suitable for native water samples 
with higher salinity. This robustness of the A-YES® offers a unique feature in comparison to 
the other commonly used in vitro assays.  
In a recent study by Saranjampour et al. (2017), the effect of salinity on water solubility and 
partitioning potential of various pesticides and crude oil constituent has been investigated. 
The authors were able to show that the environmental fate estimates using these parameters 
indicate increased chemical sorption to the sediment, general bioavailability and toxicity in 
artificial seawater. They suggested that salinity should be taken into account when exposure 
estimates are made for marine organisms. Due to the suitability of the A-YES® for saline 
water samples, the assay can be a useful method to investigate the impact of salinity on the 
combined activity of chemical mixtures. This is also relevant in terms of the WFD, as 
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Other frequently used in vitro assays for the effect-based detection of estrogens and 
estrogen-acting compounds are reporter gene assays using the yeast Saccharomyces 
cerevisiae (yeast estrogen screen assay, YES) (Routledge and Sumpter, 1996; McDonnell et 
al., 1991) or are based on human cells, e. g. cell proliferation assays such as the E-Screen 
(Soto et al., 1995) or reporter gene assays such as MELN (Balaguer et al., 1999) or ER-
CALUX® (Legler et al., 1999). The limits of quantification for the human cell-based assays 
are typically in the lower pg/L range (down to 100 pg/L), whereas the LOQ value for the YES 
is about 5 – 10 ng/L, depending on the yeast strain used (Leusch et al., 2010). Usually 
enriched/extracted samples are used for analysis, especially for the human cell-based 
assays (Leusch et al., 2010; Vanparys et al., 2010; Swart et al., 2011). This is necessary due 
to low concentrations of estrogens in many samples (lower pg/L range) and the requirements 
of the WFD for the EQS of EE2. Enrichment/extraction also reduces effects of interfering 
matrix components and microbial load, affecting cell metabolism and causing cell death.  
Nevertheless, native water samples, especially waste water samples, are analyzed using 
these assays (Escher et al., 2008; Gehrmann et al., 2016). But the YES and E-Screen are 
less applicable for untreated samples with higher salinity (Kase et al., 2008). A recent study 
on methods for the analysis of waste water reported that cytotoxicity caused by matrix 
composition was lowest for the A-YES® in comparison to the YES and ER-CALUX® with 
T47D cells (Gehrmann et al., 2016). Within the interlaboratory study, it was also possible to 
demonstrate that the A-YES® can be used for the analysis of waste water samples because 
low cell toxicity was observed and the reproducibility was very good.  
Sample matrix effects and calculation of EEQ 
An important issue concerning effect-based in vitro assays is the calculation of reliable EEQs 
of the analyzed samples. Several approaches for the calculation are applied and described in 
various publications (Kunz et al. 2017, Gehrmann et al. 2016, Escher et al. 2008). If the 
effective concentration values of the sample dose-response curve are used (e.g. EC10 or 
EC50, OECD (2016)), results from samples can deviate, showing no linear relationship 
between dilution and EEQ. In some cases, dose-response curves of complex samples have 
no parallelism to dose-response curves of the corresponding calibration standard. Thus, 
calculated EEQs have greater uncertainty, and estrogenicity of the samples is often 
underestimated (Vermeissen et al. 2006). In this interlaboratory study some of the analyzed 
samples revealed these characteristics.  
Although one can consider such effects revealed by effect-based in vitro assays as a 
drawback, it should always be kept in mind that bioassays measure the cumulative effect of a 
sample, thus of complex mixtures. Therefore, it cannot be assumed that effects are linear to 
dilution, or relating directly to health outcomes in an intact organism. The sum of the 
individual effects does not necessarily correspond to the effect of the mixture. However, the 
matrix effects are usually alleviated by separating the sample components. An alternative to 
reduce effects caused by the sample composition (so called matrix effects) may be the 
combination of bioassays with high performance thin layer chromatography (HPTLC). After 
chromatographic separation of sample constituents, the bioassay test organism is directly 
applied on the HPTLC plate, allowing the bioassay response to be evaluated after 
incubation. For example, Chamas et al. (2017) describes the combination of a 
chromatographic separation and yeast-based reporter assays for estrogens, androgens and 
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chromatography with a Saccharomyces cerevisiae based assay for detection of estrogenic 
compounds. Nevertheless, these assays require special instrumentations and are more 
difficult to perform than the 96-well plate assays while often offering a poorer sensitivity.  
However, for using the A-YES® assay as routine method it is important that sample matrix 
effects are examined, that the calculation of the EEQ is standardized, and that it is precisely 
documented to which dilution the calculated EEQ refers. This is particularly important for the 
comparability of results within and between laboratories.  
Based on the results of the interlaboratory trial, it is recommended to examine samples in 
several dilutions and to use the EC20 approach for quantification for the A-YES
®, if possible. 
More importantly, the test report should indicate whether or not the dose-response curve of 
the sample is parallel to the E2 reference.  
The matrix effects should be considered for any cases of risk or legal assessment of 
environmental samples, depending on the risk of an incorrect assessment and the 
consequences of exceeding a threshold value.  
5 Conclusions 
This interlaboratory study demonstrated that the A-YES® is a suitable tool for effect-based 
analysis of estrogen-acting compounds and can be applied as routine method. All 
unexperienced participants successfully established the A-YES® within a brief period, i.e., 
within two weeks and the participants fulfilled the validity criteria by a high degree. It was 
demonstrated in this validation study that the A-YES® is suitable for analyzing different 
sample types, including surface, coastal, and marine water, waste water influent and effluent 
as well as chemicals.  
The relative repeatability and reproducibility standard deviation of the A-YES® is comparable 
to chemical analysis methods including LC-MS-MS and GC-MS, and the assay is able to 
detect the estrogenic activity in the low ng/L range for untreated samples. Applying 
enrichment for estrogen acting substances in water samples with an appropriate enrichment 
factor, the A-YES® could be a feasible screening tool for monitoring the compliance of water 
samples with the proposed EQS for E2 and EE2 according to the WFD.  
The results of the interlaboratory study have been included in the ISO draft standard. The 
study clearly underpins that the A-YES® is a less time-consuming and straightforward 
method to screen for estrogenic potentials, and can be applied in the fields of environmental 
monitoring in freshwater and marine habitats, waste water treatment, as well as in risk 
assessment of chemical compounds. The A-YES® can be included in analytical procedures 
incorporating bioanalytical, targeted and non-targeted approaches to achieve more 
comprehensive and effect-based monitoring strategies.  
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